Polymorphism and solvatomorphism 2010

Journal of Pharmaceutical Sciences
Harry G Brittain

Abstract

Papers and patents that deal with polymorphism (crystal systems for which a substance can exist in structures defined by different unit cells and where each of the forms has the same elemental composition) and solvatomorphism (systems where the crystal structures of the substance are defined by different unit cells but where these unit cells differ in their elemental composition through the inclusion of one or molecules of solvent) have been summarized in an annual review. The works cited in this review were published during 2010 and were drawn from the major physical, crystallographic, and pharmaceutical journals. The review is divided into sections that cover articles of general interest, computational and theoretical studies, preparative and isolation methods, structural characterization and properties of polymorphic and solvatomorphic systems, studies of phase transformations, effects associated with secondary processing, and US patents issued during 2010.

References

Feb 26, 1999·Journal of Digital Imaging·B Williamson
Oct 2, 2002·Evolution; International Journal of Organic Evolution·Stephen Bernstein, Ruth Bernstein
Nov 23, 2006·Journal of Pharmaceutical Sciences·Harry G Brittain
Jan 30, 2008·Journal of Pharmaceutical Sciences·Harry G Brittain
Sep 23, 2008·Journal of Pharmaceutical Sciences·Harry G Brittain
May 29, 2009·Journal of Pharmaceutical Sciences·K KaminskiW Sawicki
Jul 2, 2009·Journal of Pharmaceutical Sciences·F TianJ Rantanen
Jul 16, 2009·Journal of Pharmaceutical Sciences·Katie M Lutker, Adam J Matzger
Jul 23, 2009·Journal of Pharmaceutical Sciences·Paroma ChakravartyRaj Suryanarayanan
Aug 6, 2009·Journal of Pharmaceutical Sciences·Fabio Furlan FerreiraCarlos de Oliveira Paiva-Santos
Sep 1, 2009·Journal of Pharmaceutical Sciences·Kohsaku KawakamiItsuro Takenoshita
Sep 1, 2009·Journal of Pharmaceutical Sciences·Reshmi ChakkittakandyPaul C M Planken
Oct 3, 2009·Journal of Pharmaceutical and Biomedical Analysis·Pradeep GhugareZoeb Filmwala
Oct 3, 2009·Journal of Pharmaceutical Sciences·Daniel PolenskeAndreas Seidel-Morgenstern
Oct 3, 2009·Journal of Pharmaceutical Sciences·Morten AllesøJukka Rantanen
Oct 13, 2009·Journal of Pharmaceutical and Biomedical Analysis·Zoltán NémetAdám Demeter
Oct 14, 2009·Journal of Pharmaceutical Sciences·Paroma ChakravartyRaj Suryanarayanan
Oct 15, 2009·Journal of Pharmaceutical Sciences·R BettiniL Pellegrino
Oct 17, 2009·Journal of Pharmaceutical and Biomedical Analysis·K KachrimanisS Malamataris
Nov 7, 2009·Journal of Pharmaceutical Sciences·Henry H Y TongChak K Chan
Dec 22, 2009·Journal of Pharmaceutical and Biomedical Analysis·G BruniA Marini
Dec 29, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Takako IshiguroKaneto Uekama
Jan 22, 2010·Journal of Pharmaceutical Sciences·Brendan J MurphyJoseph F Krzyzaniak
Jan 27, 2010·Acta Crystallographica. Section B, Structural Science·Patrick DerollezMarc Descamps
Jan 30, 2010·Journal of Pharmaceutical Sciences·Marco B PranzoRuggero Bettini
Feb 4, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Piotr KuśPeter G Jones
Feb 4, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Krishnan Ravikumar, Balasubramanian Sridhar
Mar 6, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Kazuma GotohHiroyuki Ishida
Mar 6, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Agnieszka CzapikMaria Gdaniec
Mar 11, 2010·International Journal of Pharmaceutics·C B RomañukM E Olivera
Mar 20, 2010·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sai Prasanth ChamarthyRodolfo Pinal
Mar 23, 2010·Acta Crystallographica. Section B, Structural Science·Carl Henrik Görbitz
Mar 23, 2010·Acta Crystallographica. Section B, Structural Science·E J Chan, T R Welberry
Mar 30, 2010·Journal of Pharmaceutical and Biomedical Analysis·Elisabetta MaccaroniNorberto Masciocchi
Apr 1, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Agnieszka Czapik, Maria Gdaniec
Apr 27, 2010·International Journal of Pharmaceutics·Tommi Virtanen, Sirkka L Maunu
May 6, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Elisabeth M FatilaKathryn E Preuss
May 21, 2010·Acta Crystallographica. Section B, Structural Science·Heng-Yun YeRen-Gen Xiong
May 22, 2010·Pharmaceutical Research·Niraj S TrasiStephen Robert Byrn
Jun 5, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Barbara Wicher, Maria Gdaniec
Jun 5, 2010·Acta Crystallographica. Section C, Crystal Structure Communications·Krishnan Ravikumar, Balasubramanian Sridhar
Jun 10, 2010·Journal of Pharmaceutical Sciences·Romina RuscicaDaniel R Vega

❮ Previous
Next ❯

Citations

Jul 23, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jangmi LeeEun Hee Lee
Mar 12, 2013·Acta Crystallographica. Section E, Structure Reports Online·Elena A BuvayloBrian W Skelton
Nov 12, 2013·International Journal of Pharmaceutics·Keiko NagaiKeiji Yamamoto
Feb 5, 2015·Journal of Pharmaceutical Sciences·Jadwiga FrelekWojciech J Szczepek
Jul 23, 2013·Journal of Pharmaceutical Sciences·Milena SorrentiMino R Caira
Oct 9, 2012·Journal of Pharmaceutical Sciences·Giovanni Li DestriFrancesco Punzo
Apr 23, 2014·Journal of Pharmaceutical Sciences·Xiaoying WangYang Lu
Nov 8, 2012·Journal of Pharmaceutical Sciences·Aurelien MahieuMarc Descamps
Nov 30, 2012·Journal of Pharmaceutical Sciences·Harry G Brittain
Mar 18, 2015·Journal of Pharmaceutical Sciences·Zoran LavričStane Srčič
Sep 5, 2012·International Journal of Pharmaceutics·Dhara RaijadaJukka Rantanen
Jul 21, 2012·Steroids·Kari V AhonenErkki T Kolehmainen
May 14, 2016·Acta Pharmaceutica Sinica. B·Jinju NieYang Lu
Sep 17, 2013·Pharmaceutical Development and Technology·Andrea Mariela Araya-SibajaSilvia Lucia Cuffini
Apr 16, 2014·International Journal of Pharmaceutics·Kristīne Krūkle-Bērziņa, Andris Actiņš
May 1, 2016·Journal of Pharmaceutical Sciences·Dezhi YangYang Lu
Apr 6, 2017·Acta Crystallographica. Section C, Structural Chemistry·Yun Deng WuAi Hua Zhang
Aug 1, 2014·Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials·Piyush PaniniDeepak Chopra
Apr 23, 2015·Chemistry : a European Journal·Mihaela Cibian, Garry S Hanan
Dec 3, 2016·Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials·Jacky S Bouanga Boudiombo, Ayesha Jacobs
Oct 6, 2017·Acta Crystallographica Section B, Structural Science, Crystal Engineering and Materials·Dhananjay Dey, Deepak Chopra
May 18, 2020·Natural Products and Bioprospecting·Peng-Hui YuanGuan-Hua Du
Jan 14, 2020·Journal of Pharmaceutical Analysis·Andrea Mariela Araya-SibajaSilvia Lucía Cuffini
Mar 25, 2019·Journal of Pharmaceutical Sciences·Mansour LatrecheFlorence Danède

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.